Literature DB >> 12450190

A retrospective study of the incidence and prognostic factors of multicentric lymphoma in dogs (1998-2000).

D Jagielski1, R Lechowski, M Hoffmann-Jagielska, S Winiarczyk.   

Abstract

Sixty-three dogs with multicentric lymphoma were evaluated for risk of diseases. The greatest risk of disease concerned rottweilers as compared to other breeds (odds ratio 6.01 to 0.32-2.75, respectively). A group of 43 dogs under chemotherapy was evaluated for defining factors influencing first remission time duration and survival time. The most important factors for results of chemotherapy were response to therapy, stage and sub-stage of disease according the World Health Organization staging system at the time of diagnosis.

Entities:  

Mesh：

Year:  2002        PMID： 12450190     DOI： 10.1046/j.1439-0442.2002.00458.x

Source DB:  PubMed          Journal:  J Vet Med A Physiol Pathol Clin Med        ISSN： 0931-184X


  10 in total

1.  Gamma/delta T-cell lymphoma in a dog.

Authors:  Petra Borska; Martin Faldyna; Jan Blatny; Lenka Leva; Monika Vejrostova; Jaroslav Doubek; Peter F Moore
Journal:  Can Vet J       Date:  2009-04       Impact factor: 1.008

2.  Dissecting the regulatory microenvironment of a large animal model of non-Hodgkin lymphoma: evidence of a negative prognostic impact of FOXP3+ T cells in canine B cell lymphoma.

Authors:  Dammy Pinheiro; Yu-Mei Chang; Hannah Bryant; Balazs Szladovits; Tim Dalessandri; Lucy J Davison; Elizabeth Yallop; Emily Mills; Chiara Leo; Ana Lara; Anneliese Stell; Gerry Polton; Oliver A Garden
Journal:  PLoS One       Date:  2014-08-13       Impact factor: 3.240

3.  Breed prevalence of canine lymphoma in South Africa.

Authors:  Liesl J Van Rooyen; Emma Hooijberg; Fred Reyers
Journal:  J S Afr Vet Assoc       Date:  2018-03-08       Impact factor: 1.474

4.  Evaluation of serum thymidine kinase 1 activity as a biomarker for treatment effectiveness and prediction of relapse in dogs with non-Hodgkin lymphoma.

Authors:  Pierre Boyé; Franck Floch; François Serres; Kévyn Geeraert; Pierre Clerson; Xavier Siomboing; Mattias Bergqvist; Gabriel Sack; Dominique Tierny
Journal:  J Vet Intern Med       Date:  2019-05-25       Impact factor: 3.333

5.  Establishing a model system for evaluating CAR T cell therapy using dogs with spontaneous diffuse large B cell lymphoma.

Authors:  M Kazim Panjwani; Matthew J Atherton; Martha A MaloneyHuss; Kumudhini P Haran; Ailian Xiong; Minnal Gupta; Irina Kulikovsaya; Simon F Lacey; Nicola J Mason
Journal:  Oncoimmunology       Date:  2019-10-23       Impact factor: 8.110

Review 6.  Bite-size introduction to canine hematologic malignancies.

Authors:  Matthew J Atherton; Nicola J Mason
Journal:  Blood Adv       Date:  2022-07-12

7.  Clinical outcome and Ki67 evaluation in dogs with nodal small cell B-cell lymphoma diagnosed by flow cytometry.

Authors:  Emily D Rout; Monica Fernandez; Janna A Yoshimoto; Kelly L Hughes; Anne C Avery; Jenna H Burton
Journal:  J Vet Intern Med       Date:  2022-08-23       Impact factor: 3.175

8.  Rottweilers under primary veterinary care in the UK: demography, mortality and disorders.

Authors:  Dan G O'Neill; Wee Yin Seah; David B Church; Dave C Brodbelt
Journal:  Canine Genet Epidemiol       Date:  2017-11-22

9.  Demographic risk factors for lymphoma in Australian dogs: 6201 cases.

Authors:  Peter F Bennett; Rosanne Taylor; Peter Williamson
Journal:  J Vet Intern Med       Date:  2018-10-11       Impact factor: 3.333

10.  Breed-associated risks for developing canine lymphoma differ among countries: an European canine lymphoma network study.

Authors:  Stefano Comazzi; Stefano Marelli; Marzia Cozzi; Rita Rizzi; Riccardo Finotello; Joaquim Henriques; Josep Pastor; Frederique Ponce; Carla Rohrer-Bley; Barbara C Rütgen; Erik Teske
Journal:  BMC Vet Res       Date:  2018-08-06       Impact factor: 2.741
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.